Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

What's Going On With AbbVie Stock Today? - AbbVie (NYSE:ABBV)

Summary by Benzinga
Shares of AbbVie Inc. (NASDAQ:ABBV) are moving lower Wednesday. The stock appears to be trending down after a competitor announced significant progress made on a treatment for plaque psoriasis. AbbVie shares are sliding. Why is ABBV stock falling? Protagonist Announces FDA Approval Protagonist Therapeutics announced that the FDA approved Icotyde, an interleukin-23 (IL-23) receptor antagonist for the treatment of moderate-to-severe plaque psoria…

1 Articles

BenzingaBenzinga
Center

What's Going On With AbbVie Stock Today? - AbbVie (NYSE:ABBV)

Shares of AbbVie Inc. (NASDAQ:ABBV) are moving lower Wednesday. The stock appears to be trending down after a competitor announced significant progress made on a treatment for plaque psoriasis. AbbVie shares are sliding. Why is ABBV stock falling? Protagonist Announces FDA Approval Protagonist Therapeutics announced that the FDA approved Icotyde, an interleukin-23 (IL-23) receptor antagonist for the treatment of moderate-to-severe plaque psoria…

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Wednesday, March 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

North Chicago icon

North Chicago

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal